Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Microbiota injury is conditioning regimen-dependent in allogeneic hematopoietic cell transplantation recipients
    Meeting Abstract

    Shouval, R.; Gomes, A.; Nguyen, C.; Markey, K. A.; Dai, A.; Zuanelli Brambilla, C.; Taur, Y.; Scordo, M.; Giralt, S. A.; Perales, M. A.; more...
    Bone Marrow Transplantation (2021)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation in patients with cerebral adrenoleukodystrophy: Outcomes by donor cell source and match, conditioning regimen, and stage of cerebral disease
    Meeting Abstract

    Chiesa, R.; Boelens, J. J.; Duncan, C.; Kühl, J. S.; Sevin, C.; Kapoor, N.; Prasad, V.; Lindemans, C.; Jones, S.; Amartino, H.; more...
    Bone Marrow Transplantation (2021)

    Fulltext@MSK | Save
  • In vivo B-cell depletion with myeloablative conditioning for umbilical cord blood transplant in Hurler Syndrome abolishes immune mediated cytopenia and graft rejection
    Meeting Abstract

    Nataraj, R. H.; Bonney, D.; Campbell, H.; Jones, S.; Deambrosis, D.; Hiwarkar, P.; Evans, P.; Poulton, K.; Hasselt, P. M. V.; Bierings, M. B.; more...
    Bone Marrow Transplantation (2021)

    Fulltext@MSK | Save
  • Overall survival by best overall response with tabelecleucel in patients with Epstein-Barr virus-driven post-transplant lymphoproliferative disease after allogeneic hematopoietic cell transplant
    Meeting Abstract

    Prockop, S.; Gamelin, L.; Dinahavi, R.; Sun, Y.; Guzman-Becerra, N.; Parmar, H.
    Bone Marrow Transplantation (2021)

    Fulltext@MSK | Save
  • Decreased neuroprotective analytes on day of infusion of chimeric antigen receptor (CAR) T cells are associated with neurotoxicity
    Meeting Abstract

    Lakkaraja, M.; Hosszu, K.; McAvoy, D.; Mauguen, A.; Purdon, T. J.; Khakoo, Y.; Santomasso, B. D.; Riviere, I.; Sadelain, M.; Curran, K. J.; more...
    Bone Marrow Transplantation (2021)

    Fulltext@MSK | Save
  • Phase 3 APACT trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P + Gem) vs gemcitabine (Gem) alone in patients with resected pancreatic cancer (PC): Updated 5-year overall survival
    Meeting Abstract

    Tempero, M.; O'Reilly, E.; Van Cutsem, E.; Berlin, J.; Philip, P.; Goldstein, D.; Tabernero, J.; Borad, M.; Bachet, J.; Parner, V.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Initial data from the phase 3 KEYNOTE-811 study of trastuzumab and chemotherapy with or without pembrolizumab for HER2-positive metastatic gastric or gastroesophageal junction (G/GEJ) cancer
    Meeting Abstract

    Janjigian, Y.; Kawazoe, A.; Weber, P.; Luo, S.; Lonardi, S.; Kolesnik, O.; Barajas, O.; Bai, Y.; Shen, L.; Tang, Y.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Response to total neoadjuvant therapy and survival in patients with early onset locally advanced rectal cancer
    Meeting Abstract

    Lumish, M.; Do, E.; Gonen, M.; Yaeger, R.; Weiser, M.; Cercek, A.
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • ANCHOR CRC: Results from a single-arm, phase 2 study of encorafenib, binimetinib plus cetuximab in previously untreated BRAF V600E-mutant metastatic colorectal cancer
    Meeting Abstract

    Van Cutsem, E.; Taieb, J.; Yaeger, R.; Yoshino, T.; Maiello, E.; Elez, E.; Dekervel, J.; Ross, P.; Ruiz Casado, A.; Graham, J.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Final overall survival for the phase 3 KN177 study: Pembrolizumab versus chemotherapy in microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer
    Meeting Abstract

    André, T.; Shiu, K.; Kim, T.; Jensen, B.; Jensen, L.; Punt, C.; Smith, D.; Garcia-Carbonero, R.; Alcaide García, J.; Gibbs, P.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save